AAPGV Stock: Ascentage Pharma Group International Stock Price, Analysis & Insights

Get live AAPGV stock price $17.38, comprehensive Ascentage Pharma Group International stock analysis, charts, news, and expert forecast. Real-time AAPGV stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

17.38

0.75%Today

AAPGV • Ascentage Pharma Group International • Other OTC • Healthcare

Market Cap

127.31M

Volume

2.22M

52W High

18.00

52W Low

16.50

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Ascentage Pharma Group International is a clinical-stage biotechnology company focused on developing therapeutic solutions for various cancers, chronic hepatitis B virus (HBV) infection, and age-related conditions, primarily within Mainland China. It...

Contact Information

Website: https://www.ascentage.cn
Address: Suzhou Industrial Park
Country: CN

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Ascentage Pharma Group International shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Ascentage Pharma Group International
⚠Investors should consider how Ascentage Pharma Group International fits within their overall portfolio allocation

Market Cap

127.31M

Beta

1.10

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare AAPGV with peer companies:

aTyr Pharma, Inc. (ATYR)

Price: $0.47
Market cap: 45.93M

Big Cypress Acquisition Corp. (BCYP)

Price: $8.44
Market cap: 425.36M

Cyteir Therapeutics, Inc. (CYT)

Price: $3.02
Market cap: 108.71M

Decibel Therapeutics, Inc. (DBTX)

Price: $4.91
Market cap: 123.37M

Graybug Vision, Inc. (GRAY)

Price: $5.50
Market cap: 120.98M

Kinnate Biopharma Inc. (KNTE)

Price: $2.65
Market cap: 124.99M

NGM Biopharmaceuticals, Inc. (NGM)

Price: $1.54
Market cap: 128.53M

Paratek Pharmaceuticals, Inc. (PRTK)

Price: $2.23
Market cap: 127.83M

Strongbridge Biopharma plc (SBBP)

Price: $2.00
Market cap: N/A

Sesen Bio, Inc. (SESN)

Price: $0.63
Market cap: 127.96M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.